177Lu-PSMA-617
novartis
['crpc', 'prostate']
subgroup analysis of #vision study shows improved rpfs and os with [177]lu-psma-617 in men with mcrpc regardless of prior or concomitant treatment, presented by nitin vaishampayan, md #asco22 #prostatecancer 
Interim Chair/Executive Director @GUUrology Husband to @tarablelawyer??@Patriots @Arsenal @NotreDame @NHLBruins Superstar at the cracker factory VIEWS MINE